HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group

Autor: Camilleri-Broët, S. *, Hardy-Bessard, A.C., Le Tourneau, A., Paraiso, D., Levrel, O., Leduc, B., Bain, S., Orfeuvre, H., Audouin, J., Pujade-Lauraine, E.
Zdroj: In Annals of Oncology January 2004 15(1):104-112
Databáze: ScienceDirect